Please provide your email address to receive an email when new articles are posted on . Any bleeding event regardless of severity can adversely impact a patient. Factor XI and XIa inhibitors in ...

The population-based study from the U.K. showed that taking an SSRI and OAC (both direct OACs and vitamin K antagonists [VKAs]) together was associated with a 33% increased risk of major bleeding ...

When used as primary prevention, aspirin reduces the risk that patients will experience a cardiovascular event, a new meta-analysis confirms. But that benefit is largely canceled out by an increased ...

Two of three commonly prescribed non-vitamin K oral anticoagulants (NOACs)—dabigatran and apixaban—have similar rates of major bleeding compared with aspirin, a large systematic review and ...

We evaluated 352 patients who had acute major bleeding within 18 hours after administration of a factor Xa inhibitor. The patients received a bolus of andexanet, followed by a 2-hour infusion. The ...

Aspirin Bottle Aspirin may be linked to an increased risk of major bleeding and decreased risk of cardiovascular events in individuals without cardiovascular disease. Researchers from London, United ...

Please provide your email address to receive an email when new articles are posted on . In a meta-analysis, researchers observed that severe direct oral anticoagulant-related bleeding death was ...

In the CKD population treated with oral anticoagulants for atrial fibrillation, major bleeding is more likely in male patients and those with congestive heart failure, vascular disease, and a history ...

Bleeding in ET can range from minor mucocutaneous events to severe hemorrhages, with gastrointestinal bleeding being most common. The JAK2 V617F variant increases bleeding and thrombosis risk, ...